Beijing Haitai United Pharmaceutical Technology Development

Beijing Haitai United Pharmaceutical Technology Development is a China-based pharmaceutical research and development company that focuses on both innovative drug discovery and high-end generic medications. Founded in 2004 and headquartered in Beijing, the company operates as a comprehensive Contract Research Organization (CRO) while maintaining its own internal product pipeline. Their expertise spans drug synthesis, formulation development, and clinical trial management, with a particular emphasis on the consistency evaluation of generic drugs for the Chinese market. The company's therapeutic focus includes metabolic diseases, cardiovascular health, and oncology. Haitai United is recognized as a high-tech enterprise within the Beijing Economic-Technological Development Area.